• Twitter
  • Facebook

Terms & conditions  Cookie policy   Privacy policy

Copyright © Cancer52. All rights reserved.

Cancer52 is registered as a charity in England and Wales (1174569) and a company limited by guarantee in England and Wales (7994413)

29 Oct 2019

Rapid Diagnostic Centres (RDCs) and the roll out of personalised care are cornerstones of the implementation plans for Cancer Alliances in delivering the NHS Long Term Plan.

RDCs are of particular significance to rare and less common cancers because of their initial f...

18 Oct 2019

The annual All Stakeholder Briefing was a great success and we had a good turnout of both member organisations and pharmaceutical companies. 

David Fitzgerald, Cancer Programme Director at NHS England, presented an update on the NHS Long Term Plan, explaining tha...

12 Jul 2019

The All Members meeting was a very informative and enjoyable session, which featured a mix of great speakers. 

Jennifer Mitchell and Laura Thomas from Brighter Together who are our policy advisers presented on what our recent members survey on where we are now with the...

10 Jul 2019

On Wednesday 10th July we launched a new report, ‘Getting a better deal for people with rare and less common cancers: what we can learn from patients’ at an event for MPs at Portcullis House, Houses of Parliament. 

The report was based on a patient survey conducted in 2...

24 Jun 2019

Cancer52 held a roundtable on 4th April 2019 to explore the implications of the NHS Long Term Plan and what it means for rare and less common cancers.

Following opening remarks from Jane Lyons, Chair, and David Fitzgerald, NHS England, attendees discussed three question...

11 Apr 2019

The All Member Meeting featured a great mix of speakers - Jess Mills of Act for Cancer;  and Mary-Jo Pryor of NHSE Specialised Commissioning.

Mary-Jo's and her team have taken away some questions to answer, and we are jointly hoping that she and her team may be able to...

30 Jan 2019

We had a very informative All Member Meeting on 23rd January with great presentations from both Dr Paul Catchpole, Value & Access Director of the ABPI, and David Fitzgerald, National Cancer Programme Director at NHS England.

David faced a number of questions on how the...

17 Dec 2018

Slides from the recent Briefing on the 2019 Voluntary Scheme for Branded Medicines from the Association of the British Pharmaceutical Industry (ABPI) & the Department for Health and Social Care (DHSC), held on 5 December, can be viewed here.

5 Dec 2018

It was great to see some of you at the Britain Against Cancer conference on 4 December and thank you to those of you – or your patients - who were caught on camera for our film aimed at capturing the patient voice regarding ambition for the NHS Long Term Plan.


25 Oct 2018

When a person is diagnosed with cancer in the UK information about them is automatically included in their national cancer registry.

It is data from cancer registries that tells us how many people are diagnosed with cancer, what treatments they have, how long they live,...

Please reload